175 related articles for article (PubMed ID: 34415268)
1. A Case of Post-COVID-19-Associated Paracentral Acute Middle Maculopathy and Giant Cell Arteritis-Like Vasculitis.
Jonathan GL; Scott FM; Matthew KD
J Neuroophthalmol; 2021 Sep; 41(3):351-355. PubMed ID: 34415268
[TBL] [Abstract][Full Text] [Related]
2. PARACENTRAL ACUTE MIDDLE MACULOPATHY IN GIANT CELL ARTERITIS.
Pellegrini F; Mairot K; Cuna A; Lee AG
Retin Cases Brief Rep; 2024 May; 18(3):285-289. PubMed ID: 36730607
[TBL] [Abstract][Full Text] [Related]
3. Paracentral Acute Middle Maculopathy as the Initial Presentation of Giant Cell Arteritis.
Broyles H; Chacko J; Chancellor J; LoRusso F; Phillips PH; Mashayekhi A; Uwaydat S
J Neuroophthalmol; 2021 Jun; 41(2):e157-e159. PubMed ID: 33770010
[No Abstract] [Full Text] [Related]
4. Paracentral acute middle maculopathy following SARS-CoV-2 infection: the D-dimer hypothesis.
Padhy SK; Dcruz RP; Kelgaonkar A
BMJ Case Rep; 2021 Mar; 14(3):. PubMed ID: 33664047
[No Abstract] [Full Text] [Related]
5. Paracentral Acute Middle Maculopathy as a Manifestation of Giant Cell Arteritis.
Ahuja AS; El-Dairi MA; Hadziahmetovic M; Gospe SM
J Neuroophthalmol; 2021 Jun; 41(2):e153-e156. PubMed ID: 33449486
[No Abstract] [Full Text] [Related]
6. PARACENTRAL ACUTE MIDDLE MACULOPATHY IN GIANT CELL ARTERITIS.
Mairot K; Sené T; Lecler A; Philibert M; Clavel G; Hemmendinger A; Denis D; Vignal-Clermont C; Mauget-Faÿsse M; Hage R
Retina; 2022 Mar; 42(3):476-484. PubMed ID: 34723898
[TBL] [Abstract][Full Text] [Related]
7. Cilioretinal artery occlusion with paracentral acute middle maculopathy associated with COVID-19.
Ozsaygılı C; Bayram N; Ozdemir H
Indian J Ophthalmol; 2021 Jul; 69(7):1956-1959. PubMed ID: 34146068
[TBL] [Abstract][Full Text] [Related]
8. Pellegrini et al-"Reply to: Paracentral Acute Middle Maculopathy as a Manifestation of Giant Cell Arteritis": Response.
Ahuja AS; El-Dairi MA; Hadziahmetovic M; Gospe SM
J Neuroophthalmol; 2022 Jun; 42(2):e533-e534. PubMed ID: 34803138
[No Abstract] [Full Text] [Related]
9. Giant Cell Arteritis after COVID-19 Vaccination with Long-Term Follow-Up: A Case Report and Review of the Literature.
Yoshimoto K; Kaneda S; Asada M; Taguchi H; Kawashima H; Yoneima R; Matsuoka H; Tsushima E; Ono S; Matsubara M; Yada N; Nishio K
Medicina (Kaunas); 2023 Dec; 59(12):. PubMed ID: 38138230
[TBL] [Abstract][Full Text] [Related]
10. Development of giant cell arteritis after vaccination against SARS-CoV2: A case report and literature review.
Wakabayashi H; Iwayanagi M; Sakai D; Sugiura Y; Hiruta N; Matsuzawa Y; Kaneko K
Medicine (Baltimore); 2023 Jun; 102(22):e33948. PubMed ID: 37266628
[TBL] [Abstract][Full Text] [Related]
11. Stroke as an atypical initial presentation of giant cell arteritis.
Kuganesan T; Huang AR
BMC Geriatr; 2018 Feb; 18(1):55. PubMed ID: 29466947
[TBL] [Abstract][Full Text] [Related]
12. Paracentral Acute Middle Maculopathy as the Presenting Manifestation of Giant Cell Arteritis.
Pellegrini F; Brocca D; Calandriello L; Cuna A; Leonardi F; Lee AG
J Neuroophthalmol; 2023 Dec; 43(4):e188-e191. PubMed ID: 35234683
[No Abstract] [Full Text] [Related]
13. Giant cell arteritis with normal inflammatory markers: case report and review of the literature.
Martins P; Teixeira V; Teixeira FJ; Canastro M; Palha A; Fonseca JE; Ponte C
Clin Rheumatol; 2020 Oct; 39(10):3115-3125. PubMed ID: 32472460
[TBL] [Abstract][Full Text] [Related]
14. Baseline clinical predictors of an ultimate giant cell arteritis diagnosis in patients referred to temporal artery biopsy.
Grossman C; Barshack I; Koren-Morag N; Ben-Zvi I; Bornstein G
Clin Rheumatol; 2016 Jul; 35(7):1817-22. PubMed ID: 26925851
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary nodules in a patient with Giant Cell Arteritis.
Pinho Dos Santos D; Fonseca JP; Romão V; Capelo J; Carragoso A
Pulmonology; 2019; 25(2):109-113. PubMed ID: 30755384
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 induced maculopathy.
Kumar A; Kumar P; Kaushik J; Dubbaka S; Manumala LK
Clin Exp Optom; 2021 Aug; 104(6):734-735. PubMed ID: 33725466
[No Abstract] [Full Text] [Related]
17. Giant Cell Arteritis Presenting with Ptosis and Diplopia.
Hiraoka D; Ishizaki J; Horie K; Matsumoto T; Suemori K; Takenaka K; Hasegawa H
Intern Med; 2021 Jul; 60(14):2333-2336. PubMed ID: 33583895
[TBL] [Abstract][Full Text] [Related]
18. Cilioretinal artery hypoperfusion and its association with paracentral acute middle maculopathy.
Pichi F; Fragiotta S; Freund KB; Au A; Lembo A; Nucci P; Sebastiani S; Gutierrez Hernandez JC; Interlandi E; Pellegrini F; Dolz-Marco R; Gallego-Pinazo R; Orellana-Rios J; Adatia FA; Munro M; Abboud EB; Ghazi N; Cunha Souza E; Amer R; Neri P; Sarraf D
Br J Ophthalmol; 2019 Aug; 103(8):1137-1145. PubMed ID: 30257961
[TBL] [Abstract][Full Text] [Related]
19. Factors associated to temporal artery biopsy result in suspects of giant cell arteritis: a retrospective, multicenter, case-control study.
González-López JJ; González-Moraleja J; Burdaspal-Moratilla A; Rebolleda G; Núñez-Gómez-Álvarez MT; Muñoz-Negrete FJ
Acta Ophthalmol; 2013 Dec; 91(8):763-8. PubMed ID: 22938720
[TBL] [Abstract][Full Text] [Related]
20. Giant cell arteritis presenting as bilateral anterior ischemic optic neuropathy: a biopsy-proven case report in Chinese patient.
Tian G; Chen W; Chen Q; Wang M; Zhao G; Li Z; Zhang J
BMC Ophthalmol; 2018 Oct; 18(1):282. PubMed ID: 30376812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
